BRYAN RAINBOLT: Open Payments
NPI 1013577873 · SUWANEE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,211 in 142 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $4,211
Food & beverage: $4,021Education: $190
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 13 | $785 |
| GENZYME CORPORATION | 16 | $624 |
| ABBVIE INC. | 14 | $427 |
| UCB, Inc. | 20 | $363 |
| Janssen Biotech, Inc. | 6 | $277 |
| Arcutis Biotherapeutics, Inc. | 15 | $229 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $210 |
| LEO Pharma Inc. | 7 | $196 |
| Galderma Laboratories, L.P. | 7 | $185 |
| Novartis Pharmaceuticals Corporation | 7 | $181 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, Bimzelx, Zoryve, NEMLUVIO, Xeomin, ADBRY.
Industry payments across GA — which companies pay providers there.
